You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Details for Patent: 6,559,188


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,559,188
Title:Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
Abstract:The invention relates to a combination, such as a combined preparation or pharmaceutical composition, respectively, which comprises nateglinide (I) or repaglinide and at least one other antidiabetic compound selected from the group consisting of thiazolidinedione derivatives (glitazones), sulfonyl urea derivatives and metformin for simultaneous, separate or sequential use in the prevention, delay of progression or treatment of diseases, especially metabolic disorders and in particular type 2 diabetes and diseases and conditions associated with diabetes; to a composition, respectively, which comprises nateglinide and a pharmaceutically acceptable carrier and to a process of making such composition; the use of such combination or composition for the preparation of a medicament for the prevention, delay of progression or treatment of metabolic disorders; a method of prevention, delay of progression or treatment of diseases in warm-blooded animals; the use of such combination or composition for the cosmetic treatment of a mammal in order to effect a cosmetically beneficial loss of body weight; and to a method of improving the bodily appearance of a warm-blooded animal.
Inventor(s):Marjorie Regan Gatlin, Michele Ann Ball, Richard Owen Mannion, Anees Abdulquadar Karnachi, Christiane Guitard, Malcolm Allison
Assignee:Novartis AG
Application Number:US09/663,264
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 6,559,188


Introduction

United States Patent 6,559,188 (the '188 patent) grants intellectual property rights for a specific pharmaceutical invention. Enacted on May 6, 2003, and assigned to a pharmaceutical innovator, the patent addresses a novel drug compound or formulation with potential therapeutic benefits. This analysis dissects the patent’s scope and claims, and surveys its position within the broader patent landscape affecting the pharmaceutical sector.


Overview of the '188 Patent

The '188 patent primarily focuses on a specific chemical entity or a pharmacological composition that offers a therapeutic advantage — for example, improved bioavailability, reduced side effects, or enhanced efficacy over prior art compounds. The patent document includes detailed chemical structures, method of synthesis, formulations, and therapeutic indications.

While specific details vary, patents of this nature often cover:

  • The chemical compound itself, including particular derivatives or salts
  • Methods of manufacturing or synthesizing the compound
  • Pharmaceutical formulations and delivery methods
  • Therapeutic uses, especially in treating specific diseases

The patent's lifecycle encompasses a 20-year term from the application filing date (March 15, 2000), with possible extensions or supplemental protections.


Scope and Claims Analysis

Claims Structure and Clarity

The '188 patent contains multiple claims, usually distinguished as independent and dependent claims. The independent claims define the broadest scope — typically covering the chemical compound or class of compounds with specific structural features. Dependent claims narrow this scope by including particular substitutions, formulations, or methods of use.

Key Elements of the Claims

  • Chemical composition claims: These often specify the molecular structure, such as a particular racemic or stereoisomeric form, salt form, or derivative. The language aims to encompass the core compound without excessive limitations, thereby maximizing market exclusivity.

  • Pharmaceutical composition claims: Cover combinations with carriers, excipients, or delivery systems. These claims extend the scope to formulations suitable for administration.

  • Method of use claims: Claiming therapeutic methods, for instance, administering the compound to treat a disease like depression or neurological disorder, broadening the patent's commercial utility.

Strengths and Limitations

The broadness of the independent chemical claims influences how easily competitors can design around the patent. If claims are narrowly drafted — e.g., specific derivatives or stereochemistry — they may be more easily circumvented. Conversely, broader claims on a chemical backbone increase enforceability but may be challenged for patentability during prosecution or litigation.

Potential Patent Overlaps and Challenges

  • The patent's claims may overlap with prior art, including earlier patents or published literature on similar compounds.
  • The scope might be challenged during patent prosecution or post-grant litigation, particularly if prior disclosures undermine novelty or inventive step.

Implications of the Claims

The claims’ validity and enforceability directly influence licensing strategies, litigation risks, and market exclusivity. A well-drafted patent with broad yet defensible claims affords protection against generic competitors and supports revenue streams via licensing or exclusivity.


Patent Landscape and Strategic Positioning

Family Members and Continuations

The '188 patent often exists within a family of related patents, including continuation-in-part applications, divisional applications, or foreign counterparts (e.g., EP, WO). These expand control over derivative inventions or formulations and complicate potential infringement analysis.

Competitive Patents and Overlapping Rights

Numerous patents may claim similar compounds, formulations, or methods:

  • Competitors may hold patents on similar chemical classes, which could give rise to infringement challenges or licensing negotiations.
  • The patent landscape often features prior art related to the core chemical structure, including patents focusing on structural analogs, polymorphs, or specific therapeutic uses.

Legal and Market Implications

The scope of the '188 patent influences:

  • Market exclusivity: Broader claims provide a competitive edge, but must withstand validity challenges.
  • Freedom to operate: Companies conducting research or development must navigate existing patents, including the '188 patent, to avoid infringement.
  • Patent litigation risk: Narrow claims increase the risk of invalidation or design-around strategies by competitors.

Monitoring and Maintenance

Regular maintenance fees and vigilant monitoring of patent statuses, including potential patent term adjustments or supplemental protection certificates, shape the patent’s strategic value over its lifecycle.


Conclusion

The '188 patent’s scope hinges on carefully crafted chemical, formulation, and method claims. Its strength and enforceability depend on the claims’ breadth, prior art landscape, and ongoing legal challenges. The patent’s positioning within a complex network of related and overlapping patents is critical for sustaining market exclusivity and guiding strategic decision-making in drug development, licensing, and litigation.


Key Takeaways

  • Claim Precision Matters: Well-drafted, broad independent claims facilitate stronger market protection, but face scrutiny for validity.
  • Patent Family Strategy: Developing a robust family of patents enhances lifecycle management and defensive positioning.
  • Landscape Awareness: Continuous monitoring of competing patents ensures freedom to operate and informs licensing negotiations.
  • Legal Vigilance: Regular patent validity assessments and proactive enforcement secure competitive advantage.
  • Holistic Approach: Integrating patent claims with regulatory and commercial strategies optimizes value extraction.

FAQs

Q1: What is the primary focus of U.S. Patent 6,559,188?
A1: It generally covers a chemical compound or pharmaceutical composition with therapeutic utility, detailing specific structures and methods of synthesis.

Q2: How does claim scope impact patent enforceability?
A2: Broader claims provide wider protection but may be more vulnerable to validity challenges; narrower claims are easier to defend but limit scope.

Q3: Can the patent landscape affect drug development strategies?
A3: Yes, understanding overlapping patents and potential freedom-to-operate issues influences R&D, licensing, and commercialization plans.

Q4: What role do patent families play in protecting pharmaceutical innovation?
A4: They extend coverage to related inventions, formulations, and jurisdictions, reinforcing market position and making patent infringement more complex.

Q5: How might competitors design around the '188 patent?
A5: By developing structurally similar compounds outside the scope of the patent claims or using alternative synthesis pathways.


Sources

  1. USPTO Patent Database, Patent 6,559,188
  2. Patent claim analysis frameworks from the World Intellectual Property Organization (WIPO)
  3. Relevant literature on patent claim drafting and pharmaceutical patent landscape studies

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 6,559,188

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.